With pharmacokinetic/pharmacodynamic modeling. Our Clinical Pharmacology team can work with you through the entire life cycle of development, from pre-IND through to regulatory submission.
IQVIA Pharmacology can support you in crafting the Model-Informed Drug Development Plan (MIDD) and help with dosing strategy and execution. If you have concerns about the FDA’s Project Optimus, we are here to help.
See how we can help support you through your pharmacology lifecycle click the icons for more info.
When it comes to early phase development our pharmacology team have a host of service and solutions to help you through this embryonic phase from:
Gain support in your label claims and special populations studies with our expert PK modeling. We have submitted modeling for more than 100 molecules and engage in industry standard processes that are accepted by the regulators. We also provide:
When you need additional support in defining the optimal dose for latter phase trials, we can help through greatly improving the probability of success. Our Pharmacokinetic modeling solutions provides better accuracy at estimating the dose and build precision dosing algorithms to further enhance study development and aid in optimizing the sample size significantly by reducing the PK variability so that only the PD variability is exhibited in the endpoints.
Our team provide responses to regulatory questions with modeling and engage with you in supporting regulatory claims through modeling and Pediatric extensions
We work with you in the development of dosing applications to support product sales and aid in precision dosing using our dedicated applications for customer support
SOMS based AI/ML analysis and genetic testing support helps sponsors speed recruitment for rare disease trials.
Better navigate the consumer healthcare marketplace and uncover your pathway to success
Ensure you have access to insights early with connected devices and clean, analysis-ready data
Clinical trials face increasing pressure to deliver new treatments to market faster. IQVIA Connected Devices accelerates trial outcomes with medical device recommendations that fit your clinical study, deliver cleaner data, and speed data collection and analysis with lower patient and site burdens.
IQVIA FSP Advance integrates expert functional resourcing with clinical services and innovative technology solutions to increase quality and efficiency – within a clinical trial or across a global R&D portfolio.
Enhance patient safety and study quality by using data, analytics, and technology to monitor patient, site, and study performance with risk-based and centralized monitoring.
Use machine learning-driven analytics to help identify promising patient subgroups, potentially preserving your investment and ensuring valuable therapies reach patients.
